Exploring the relationships between tobacco smoking and schizophrenia in first-degree relatives

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 674-678

  Ferchiou, Aziz ^a,b,c   Szöke, Andrei ^a,b,c   Laguerre, Audrey ^a,b,c   Méary, Alexandre ^a,b,c   Leboyer, Marion ^a,b,c   Schürhoff, Franck ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c FACULTÉ DE MÉDECINE   (France)

Author keywords

Genetic; Nicotine; Relatives; Schizophrenia; Schizotypy; Smoking

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIRST DEGREE RELATIVE; GENETIC RISK; HEBEPHRENIA; HUMAN; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIZOPHRENIA; SMOKING; TOBACCO DEPENDENCE;

ADULT; AGED; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SMOKING; TOBACCO USE DISORDER;

EID: 84872417422     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.07.054     Document Type: Article

References (70)

1. Addington J., el-Guebaly N., Campbell W., Hodgins D.C., Addington D. Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry 1998, 155:974-976.
2. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. American Journal of Psychiatry 1993, 150:1856-1861.
3. Aguilar M.C., Gurpegui M., Diaz F.J., de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. British Journal of Psychiatry 2005, 186:215-221.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders DSM-IV-TR fourth edition (text revision) 2000, American Psychiatric Press, Washington, D.C, pp. 297-316.
5. Arias H.F., Padin Calo J.J., Fernandez Gonzalez M.A. Drug use and dependence in schizophrenia. Actas Luso-Espanolas de Neurologia, Psyquiatria y Ciencias Afines 1997, 25:379-389.
6. Bech P., Rafaelsen O.J., Kramp P., Bolwig T.G. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978, 17:430-431.
7. Benowitz N.L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics 2008, 83:531-541.
8. Beratis S., Katrivanou A., Gourzis P. Factors affecting smoking in schizophrenia. Comprehensive Psychiatry 2001, 42:393-402.
9. Berlin I., Said S., Spreux-Varoquaux O., Olivares R., Launay J.M., Puech A.J. Monoamine oxidase A and B activities in heavy smokers. Biological Psychiatry 1995, 38:756-761.
10. Calkins M.E., Curtis C.E., Grove W.M., Iacono W.G. Multiple dimensions of schizotypy in first-degree biological relatives of schizophrenia patients. Schizophrenia Bulletin 2004, 30:317-325.
11. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 1998, 155:1490-1501.
12. Dalack G.W., Becks L., Hill E., Pomerleau O.F., Meador-Woodruff J.H. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 1999, 21:195-202.
13. de Leon J., Diaz F.J., Rogers T., Browne D., Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophrenia Research 2002, 56:47-54.
14. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviours. Schizophrenia Research 2005, 76:135-157.
15. de Leon J., Diaz F.J., Aguilar M.C., Jurado D., Gupergui M. Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophrenia Research 2006, 86:256-268.
16. Dumas P., Rosenfeld F., Saoud M., Dalery J., d'Amato T. Traduction et adpatation Française du questionnaire de personnalité schizotypique de Raine. Encéphale 1999, 25:315-322.
17. Dumas P., Bouafia S., Gutknecht C., Saoud M., Dalery J., d'Amato T. Validation de la version française du questionnaire de personnalité schizotypique de Raine-approche catégorielle et dimensionnelle des traits de personnalité schizotypique dans une population d'étudiants. Encéphale 2000, 26:23-29.
18. Esterberg M.L., Jones E.M., Compton M.T., Walker E.F. Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls. Schizophrenia Research 2007, 97:6-13.
19. Etter J.F., Duc T.V., Perneger T.V. Validity of the Fagerström test for nicotine dependence and of the heaviness of smoking index among relatively light smokers. Addiction 1999, 94:269-281.
20. Evins A.E., Mays V.K., Rigotti N.A., Tisdale T., Cather C., Goff D.C. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine and Tobacco Research 2001, 3:397-403.
21. Evins A.E., Deckersbach T., Cather C., Freudenreich O., Culhane M.A., Henderson D.C., Green M.F., Schoenfeld D.A., Rigotti N.A., Goff D.C. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. Journal of Clinical Psychiatry 2005, 66:1184-1190.
22. Fanous A., Gardner C., Walsh D., Kendler K.S. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Archives of General Psychiatry 2001, 58:669-673.
23. Faraone S.V., Su J., Taylor L., Wilcox M., Van Eerdewegh P., Tsuang M.T. A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families. Human Heredity 2004, 57:59-68.
24. Fatemi S.H., Stary J.M., Hatsukami D.K., Murphy S.E. A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia. Schizophrenia Research 2005, 76:353-356.
25. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proceedings of the National Academy of Sciences, USA 1997, 94:587-592.
26. Freedman R., Leonard S., Gault J.M., Hopkins J., Cloninger C.R., Kaufmann C.A., Tsuang M.T., Farone S.V., Malaspina D., Svrakic D.M., Sanders A., Gejman P. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). American Journal of Medical Genetics 2001, 105:20-22.
27. Freedman R., Leonard S., Olincy A., Kaufmann C.A., Malaspina D., Cloninger C.R., Svrakic D., Faraone S.V., Tsuang M.T. Evidence for the multigenic inheritance of schizophrenia. American Journal of Medical Genetics 2001, 105:794-800.
28. Fukui K., Kobayashi T., Hayakawa S., Koga E., Okazaki S., Kawashima Y., Kawakami F., Fukui Y., Tani N., Kato A. Smoking habits of chronic schizophrenics. Japanese Journal of Alcohol Studies and Drug Dependence 1995, 30:447-454.
29. Gandhi K.K., Foulds J., Steinberg M.B., Lu S.E., Williams J.M. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. International Journal of Clinical Practice 2009, 63:360-367.
30. Glynn S.M., Sussman S. Why patients smoke. Hospital and Community Psychiatry 1990, 41:1027-1028.
31. Gurpegui M., Martínez-Ortega J.M., Aguilar M.C., Diaz F.J., Quintana H.M., de Leon J. Smoking initiation and schizophrenia: a replication study in a Spanish sample. Schizophrenia Research 2005, 76:113-118.
32. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 2005, 10:40-68.
33. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
34. Herran A., De Santiago A., Sandoya M., Fernandez M.J., Diez-Manrique J.F., Vasquez-Barquero J.L. Determinants of smoking behaviour in outpatients with schizophrenia. Schizophrenia Research 2000, 41:373-381.
35. Joseph S., Manafi E., Lakovaki A.M., Cooper R. Personality, smoking motivation, and self-efficacy to quit. Personality and Individual Differences 2003, 34:749-758.
36. Kendler K.S., Neale M.C., Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon family study. American Journal of Psychiatry 1995, 152:749-754.
37. Kendler K.S., Neale M.C., Sullivan P., Corey L.A., Gardner C.O., Prescott C.A. A population-based twin study in women of smoking initiation and nicotine dependence. Psychological Medicine 1999, 29:299-308.
38. Kristensen K., Cadenhead K.S. Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research 2007, 151:151-154.
39. Larrison A.L., Briand K.A., Sereno A.B. Nicotine, caffeine, alcohol and schizotypy. Personality and Individual Differences 1999, 27:101-108.
40. Lavin M.R., Siris S.G., Mason S.E. What is the clinical importance of cigarette smoking in schizophrenia?. American Journal of Addiction 1996, 5:189-208.
41. Leonard S., Gault J., Hopkins J. Association of promoter variants in the α7 nicotine acetylcholine receptor gene with an inhibitory deficit found in schizophrenia. Archives of General Psychiatry 2002, 59:1085-1096.
42. Leonard S., Mexal S., Freedman R. Smoking, genetics and schizophrenia: evidence for self medication. Journal of Dual Diagnosis 2007, 3:43-59.
43. Lerman C., Caporaso N., Main D., Audrain J., Boyd N.R., Bowman E.D., Shields P.G. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychology 1998, 17:56-62.
44. Liu C.M., Hwu H.G., Lin M.W., Ou-Yang W.C., Lee S.F., Fann C.S., Wong S.H., Hsieh S.H. Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. American Journal of Medical Genetics 2001, 105:658-661.
45. Lyons M.J., Bar J.L., Kremen W.S., Toomey R., Eisen S.A., Goldberg J., Faraone S.V., Tsuang M. Nicotine and familial vulnerability to schizophrenia: a discordant twin study. Journal of Abnormal Psychology 2002, 111:687-693.
46. Mata I., Sham P.C., Gilvarry C.M., Jones P.B., Lewis S.W., Murray R.M. Childhood schizotypy and positive symptoms in schizophrenic patients predicts schizotypy in relatives. Schizophrenia Research 2000, 44:129-136.
47. Maxwell M.E. Family interview for genetic studies 1992, Clinical Neurogenetic Branch, Intramural Research Program, NIMH.
48. McEvoy J.P., Freudenreich O., Levin E.D., Rose J.E. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacolgy (Berlin) 1995, 119:124-126.
49. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Britsh Journal of Psychiatry 1979, 134:382-389.
50. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview of genetic studies. Rationale, unique features and training. NIMH genetics initiative. Archives of General Psychiatry 1994, 51:849-859.
51. Ochoa E.L.M., Lasalde-Dominicci J. Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking. Cellular and Molecular Neurobiology 2007, 27:609-639.
52. Olincy A., Johnson L.L., Ross R.G. Differntial effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia. Psychiatry Research 2003, 117:223-236.
53. Owen M.J., Williams N.M., O'Donovan M.C. The molecular genetics of schizophrenia: new findings promise new insights. Molecular Psychiatry 2004, 9:14-27.
54. Patkar A.A., Gopalakrishnan R., Lundy A., Leone F.T., Certa K.M., Weinstein S.P. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. Journal of Nervous and Mental Disease 2002, 190:604-610.
55. Pichot P., Lebeaux M.O., Penhouët C., Simon M. L'estimation du niveau intellectuel prémorbide à la WAIS-R. Comparaison entre la méthode de Barona et l'ndex de détérioration de Wechsler. Revue Européenne de Psychologie Appliquée 1993, 43:291-301.
56. Preisig M., Fenton B.T., Matthey M.L., Berney A., Ferrero F. Diagnostic interview of genetic studies (DIGS): inter-rater and test-retest reliability of the French version. European Archives of Psychiatry and Clinical Neuroscience 1999, 249:174-179.
57. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 1991, 17:556-564.
58. Saccone S.F., Hinrichs A.L., Saccone N.L., Chase G.A., Konvicka K., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O., Swan G.E., Goate A.M., Rutter J., Bertelsen S., Fox L., Fugman D., Martin N.G., Montgomery G.W., Wang J.C., Ballinger D.G., Rice J.P., Bierut L.J. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics 2007, 16:36-49.
59. Shields P.G., Lerman C., Audrain J., Bowman E.D., Main D., Boyd N.R., Caporaso N.E. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiology and Biomarkers Prevention 1998, 7:453-458.
60. Smith M.J., Barch D.M., Wolf T.J., Mamah D., Csernansky J.G. Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia. Schizophrenia Research 2008, 106:294-299.
61. Smith R.C., Singh A., Infante M., Khandat A., Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 2002, 27:479-497.
62. Spitz M.R., Shi H., Yang F., Hudmon K.S., Jiang H., Chamberlain R.M., Amos C.I., Wan Y., Cinciripini P., Hong W.K., Wu X. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. Journal of the National Cancer Institute 1998, 90:358-363.
63. Steinberg M.L., Williams J.M., Steinberg H.R., Krejci J.A., Ziedonis D.M. Applicability of the Fagerstrom test for nicotine dependence in smokers with schizophrenia. Addictive Behaviors 2005, 30:49-59.
64. Taiminen T.J., Salokangas R.K., Saarijärvi S., Niemi H., Lehto H., Ahola V., Syvälahti E. Smoking and cognitive deficits in schizophrenia: a pilot study. Addictive Behaviors 1998, 23:263-266.
65. Tsuang D.W., Skol A.D., Faraone S.V., Bingham S., Young K.A., Prabhudesai S., Haverstock S.L., Mena F., Menon A.S., Bisset D., Pepple J., Sauter F., Baldwin C., Weiss D., Collins J., Boehnke M., Schellenberg G.D., Tsuang M.T. Examination of genetic linkage of chromosome 15 to schizophrenia in a large veterans affairs cooperative study sample. American Journal of Medical Genetics 2001, 105:662-668.
66. Vollema M.G., Van den Bosch R.J. The multidimensionality of schizotypy. Schizophrenia Bulletin 1995, 21:19-31.
67. Weiser M., Reichenberg A., Grotto I., Yasvitzky R., Rabinowitz J., Lubin G., Nahon D., Knobler H.Y., Davidson M. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. American Journal of Psychiatry 2004, 161:1219-1223.
68. Williams J.H., Wellman N.A., Allan L.M., Taylor E., Tonin J., Feldon J., Rawlins J.N.P. Tobacco smoking correlates with schizotypal and borderline personality traits. Personality and Individual Differences 1996, 20:267-270.
69. Yoshimasu K., Kiyohara C. Genetic influences on smoking behaviour and nicotine dependence: a review. Journal of Epidemiology 2003, 13:183-192.
70. Ziedonis D.M., Kosten T.R., Glazer W.M., Frances R.J. Nicotine dependence and schizophrenia. Hospital and Community Psychiatry 1994, 45:204-206.